Imugene expands study for bile tract cancer patients
Cancer immunotherapy company Imugene Ltd (ASX: IMU) will be expanding its trial…
Imugene Limited (ASX:IMU)
About Imugene Limited
Key Information
IMU In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 19/04/2024 | Notification regarding unquoted securities - IMU | 20.68KB | 1.1K |
| 17/04/2024 | Imugene & Kincell Bio Strategic Partnership Investor Webinar | 138.92KB | 17K |
| 16/04/2024 | Price Sensitive PS Imugene and Kincell Bio Announce Strategic Partnership | 220.02KB | 60K |
| 15/04/2024 | Notification of cessation of securities - IMU | 14.65KB | 755 |
| 15/04/2024 | Notification regarding unquoted securities - IMU | 17.53KB | 611 |
| 15/04/2024 | Price Sensitive PS Bile Tract Cancer Study Opens after MAST High Dose Clearance | 217.25KB | 59K |
| 08/04/2024 | Price Sensitive PS VAXINIA and HER-Vaxx featured at the AACR Annual Meeting | 173.17KB | 116K |
| 04/04/2024 | Price Sensitive PS Oncolytic Virotherapy CF33 Patent Granted in China | 163.48KB | 54K |